Department of Molecular and Cellular Biology
Jiehua Zhou has not added Biography.
If you are Jiehua Zhou and would like to personalize this page please email our Author Liaison for assistance.
Bombesin/gastrin-releasing peptide receptor: a potential target for antibody-mediated therapy of small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research Oct, 2003 | Pubmed ID: 14581370
Targeting gastrin-releasing peptide receptors for cancer treatment.
Anti-cancer drugs Nov, 2004 | Pubmed ID: 15514561
Polycationic dendrimers interact with RNA molecules: polyamine dendrimers inhibit the catalytic activity of Candida ribozymes.
Chemical communications (Cambridge, England) Jan, 2005 | Pubmed ID: 15645021
Cooperative binding and self-assembling behavior of cationic low molecular-weight dendrons with RNA molecules.
Organic & biomolecular chemistry Feb, 2006 | Pubmed ID: 16446818
Targeting gastrin-releasing peptide receptors on small cell lung cancer cells with a bispecific molecule that activates polyclonal T lymphocytes.
Clinical cancer research : an official journal of the American Association for Cancer Research Apr, 2006 | Pubmed ID: 16609038
树形高分子高效 siRNA 交付和烈性基因沉默。
Chemical communications (Cambridge, England) Jun, 2006 | Pubmed ID: 16733580
Importance of size-to-charge ratio in construction of stable and uniform nanoscale RNA/dendrimer complexes.
Organic & biomolecular chemistry Nov, 2007 | Pubmed ID: 17971997
Novel dual inhibitory function aptamer-siRNA delivery system for HIV-1 therapy.
Molecular therapy : the journal of the American Society of Gene Therapy Aug, 2008 | Pubmed ID: 18461053
Bivalent aptamers deliver the punch.
Chemistry & biology Jul, 2008 | Pubmed ID: 18635000
Selection, characterization and application of new RNA HIV gp 120 aptamers for facile delivery of Dicer substrate siRNAs into HIV infected cells.
Nucleic acids research May, 2009 | Pubmed ID: 19304999
The therapeutic potential of cell-internalizing aptamers.
Current topics in medicinal chemistry , 2009 | Pubmed ID: 19860714
Aptamer-targeted cell-specific RNA interference.
Silence , 2010 | Pubmed ID: 20226078
CTLA-4 blockade following relapse of malignancy after allogeneic stem cell transplantation is associated with T cell activation but not with increased levels of T regulatory cells.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation May, 2011 | Pubmed ID: 20713164
Cell-specific aptamer-mediated targeted drug delivery.
Oligonucleotides Feb, 2011 | Pubmed ID: 21182455
An aptamer-siRNA chimera suppresses HIV-1 viral loads and protects from helper CD4(+) T cell decline in humanized mice.
Science translational medicine Jan, 2011 | Pubmed ID: 21248316
Dual functional RNA nanoparticles containing phi29 motor pRNA and anti-gp120 aptamer for cell-type specific delivery and HIV-1 inhibition.
Methods (San Diego, Calif.) Jun, 2011 | Pubmed ID: 21256218
Progress in RNAi-based antiviral therapeutics.
Methods in molecular biology (Clifton, N.J.) , 2011 | Pubmed ID: 21431679
Aptamer-targeted RNAi for HIV-1 therapy.
Methods in molecular biology (Clifton, N.J.) , 2011 | Pubmed ID: 21431697
Systemic administration of combinatorial dsiRNAs via nanoparticles efficiently suppresses HIV-1 infection in humanized mice.
Molecular therapy : the journal of the American Society of Gene Therapy Dec, 2011 | Pubmed ID: 21952167
Structurally flexible triethanolamine core PAMAM dendrimers are effective nanovectors for DNA transfection in vitro and in vivo to the mouse thymus.
Bioconjugate chemistry Dec, 2011 | Pubmed ID: 22053932
Current Advances in Aptamers for Cancer Diagnosis and Therapy.
Cancers Jan, 2018 | Pubmed ID: 29301363
HIV Replication and Latency in a Humanized NSG Mouse Model during Suppressive Oral Combinational Antiretroviral Therapy.
Journal of virology 04, 2018 | Pubmed ID: 29343582
SOBRE A JoVE
Copyright © 2024 MyJoVE Corporation. Todos os direitos reservados